Real World Utilization and Outcomes With Dacomitinib First Line Treatment for EGFR Mutation-positive Advanced Non Small Cell Lung Cancer Among Asian Patients - A Multi Center Chart Review
Clinical trial NCT04609319 · COMPLETED
Trial details
- NCT number
- NCT04609319
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-06-11
- Primary completion
- 2024-05-28
- Enrollment
- 307
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.